Cluster: Health Economy

Novartis given green light for infant anti-malaria drug

Novartis: Swissmedic gives green light to antimalarial for infants

This content was published on Jul 8, 2025 Swissmedic approves Novartis anti-malaria drug Coartem Baby.

New treatments

Swiss inaction threatens global antibiotic development push

This content was published on Jul 8, 2025 Switzerland risks stalling global antibiotic innovation amid rising resistance.

Food safety

Zurich laboratory finds intestinal bacteria in coffee machines

This content was published on Jul 7, 2025 Last year, the Zurich Cantonal Laboratory found defects in one in four samples of milk drinks from coffee machines. Too many intestinal bacteria were found in a number of samples.

Journalist Anand Chandrasekhar sitting at a table, holding up a picture of a chocolate bar.

Global trade

Truth or tale: is Swiss chocolate tainted by child labour?

This content was published on Jul 7, 2025 A reader asked if it was true that children are involved in cocoa production for the Swiss chocolate industry. Swissinfo tried to get to the bottom of this complex issue.

Healthcare innovation

Can Saudi Arabia’s billions unlock the secrets to a longer, healthier life?

This content was published on Jul 3, 2025 Longevity has been an underfunded area of biotech research but that is changing thanks to an unlikely source: Saudi Arabia.

Pharma supply chains

Swiss pharma firm Sandoz invests $440 million in Slovenia

This content was published on Jul 2, 2025 Sandoz is investing $440 million in Slovenia for new biosimilar centers, aiming to tap into a rapidly growing market.

Healthcare innovation

Swiss firm BioVersys signs deal with Shionogi for antibiotics research

This content was published on Jul 2, 2025 Swiss firm BioVersys and Japanese firm Shionogi have joined forces on antibiotic research.

Federal government completely revises pandemic plan due to Covid-19

Prevention

Swiss government completely revises pandemic plan due to Covid-19

This content was published on Jul 2, 2025 The Swiss government has completely revised the pandemic plan based on its experience with the coronavirus.

Janssen plant in Bern threatened with closure, 300 employees affected

Medicine access

Janssen vaccine maker considers closing Bern factory

This content was published on Jul 2, 2025 Janssen may close its historic Bern factory due to vaccine challenges and new Dutch plant plans.

A pharmacist with a customer in France offering a generic drug.

Pharma supply chains

How US tariffs could disrupt the generic drugs supply chain

This content was published on Jul 1, 2025 US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.

Page 20 of 29

First … 18 19 20 21 22 … Last

Cluster: Health Economy

Popular Stories

Most Discussed

Cluster: Health Economy

More

Novartis given green light for infant anti-malaria drug

More

Swiss inaction threatens global antibiotic development push

More

Zurich laboratory finds intestinal bacteria in coffee machines

More

Truth or tale: is Swiss chocolate tainted by child labour?

More

Can Saudi Arabia’s billions unlock the secrets to a longer, healthier life?

More

Swiss pharma firm Sandoz invests $440 million in Slovenia

More

Swiss firm BioVersys signs deal with Shionogi for antibiotics research

More

Swiss government completely revises pandemic plan due to Covid-19

More

Janssen vaccine maker considers closing Bern factory

More

How US tariffs could disrupt the generic drugs supply chain

Popular Stories

Most Discussed